Industry News (Joint Venture)

Agreement Reached for Marketing NMP22 in Spain and Portugal

Published in Cancer Weekly, May 4th, 1998

Matritech, Inc., Newton, Massachusetts, announced that it has reached an agreement on marketing and product purchase terms relating to the Matritech NMP22 Test Kit for bladder cancer with the Barcelona-based subsidiary of Organon Teknika for distribution of the product in Spain and Portugal.

David L. Corbet, Matritech, said, "We are very excited about their strong marketing capabilities as they relate to selling NMP22 in Spain."

"We wanted a bladder cancer tumor marker to add to our diagnostic portfolio which complements our bladder cancer therapy, BCG. We are extremely pleased to have concluded a distribution agreement for NMP22, which we believe...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1998-05-04)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry